Related Experiment Video
Updated: Mar 2, 2026
07:11
Morphological and Functional Assessment of the Right Ventricle Using 3D Echocardiography
Published on: October 28, 2020
3.5K
Treatment of right ventricular outflow tract dysfunction: a multimodality approach
Francesca Romana Pluchinotta1, Claudio Bussadori1, Gianfranco Butera1
1Department of Pediatric Cardiology and Adult Congenital Heart Disease - IRCCS Policlinico San Donato, San Donato Milanese (MI), Italy.
Summary
Determining the optimal time for pulmonary valve replacement in right ventricular outflow tract dysfunction remains challenging. Advanced cardiovascular imaging is being explored to aid treatment decisions and predict outcomes.
Area of Science:
- Cardiology
- Medical Imaging
- Cardiovascular Surgery
Background:
- Pulmonary valve replacement is crucial for patients with right ventricular outflow tract (RVOT) dysfunction.
- Both percutaneous pulmonary valve and surgical prosthesis are viable treatment options.
- Individualized RV remodeling and recovery post-replacement complicate treatment selection and outcome prediction.
Purpose of the Study:
- To present ongoing research focused on characterizing RVOT dysfunction.
- To identify variables and parameters using advanced cardiovascular imaging for improved decision-making.
- To optimize the treatment approach for RVOT dysfunction.
Main Methods:
- Utilizing advanced cardiovascular imaging techniques.
- Developing reproducible measurements for patient characterization.
- Analyzing patient-specific RV remodeling and recovery patterns.
Main Results:
- Ongoing research aims to optimize patient characterization through advanced imaging.
- Focus on identifying predictive variables for treatment success.
- Development of strategies to guide optimal treatment selection.
Conclusions:
- Accurate characterization of RVOT dysfunction is essential for optimal patient management.
- Advanced cardiovascular imaging holds promise for improving treatment decisions.
- Further research is needed to refine predictive models and treatment strategies.
Related Concept Videos
01:25Mitral Regurgitation III: Medical Management
450
Mitral regurgitation (MR) is characterized by retrograde blood circulation from the left ventricle into the left atrium due to inadequate mitral valve closure. The severity of the condition, symptoms, and underlying cause determine treatment strategies.Monitoring and Pharmacological TreatmentPatients with mild to moderate MR typically do not need immediate intervention but regular monitoring to assess progression and guide treatment. Patients with mild MR should have an echocardiogram every 3-5...
450
01:25Aortic Regurgitation III: Medical Management
518
Aortic regurgitation (AR) is when the aortic valve does not close or seal properly, leading to backward blood circulation from the aorta into the left ventricle during diastole. Common causes of AR include rheumatic heart disease, congenital valve defects, and aortic root dilation. Managing AR requires a multifaceted approach to alleviate symptoms, preserve left ventricular function, and address the underlying cause of the regurgitation. Patients with symptomatic AR or significant left...
518
01:26Mitral Stenosis III: Medical Management
376
Mitral stenosis, a condition marked by the narrowing of the mitral valve, necessitates an integrated approach for effective management. This approach includes preventative measures, medical therapy, and surgical interventions to reduce symptoms and prevent complications.PreventionPrevention of mitral stenosis primarily focuses on reducing the incidence of bacterial infections, particularly streptococcal infections, which can lead to rheumatic fever and subsequent valvular damage. Timely...
376
01:29Cardiomyopathy V: Interprofessional Care
551
Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
551
01:22Heart Failure VI: Adjunct Therapies
474
Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
474
01:29Cardiomyopathy III: Hypertrophic Cardiomyopathy
578
Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
578